Hypopituitarism Health Dictionary

Hypopituitarism: From 4 Different Sources


Diminished function of the pituitary gland with insufficient production of hormones. Children fail to develop and may be small. Tumour accounts for many cases. May occur from pituitary damage due to severe major haemorrhage (Sheehan’s syndrome).

Symptoms. Fatigue, weight loss, sense of weakness, low blood pressure, visual problems, headaches. Adults – hair loss. Women – absence of menstruation; unable to provide milk after pregnancy. Feeble sex drive. Few specifics exist, yet any of the following provides a basic stimulation for the whole endocrine system.

Alternatives. Sarsaparilla, Walnut, Prickly Ash, Ginseng, Wild Yam, Ginkgo, Gotu Kola.

The action of these herbs upon the endocrine system appears to be one of ‘normalising’ – decreasing over-activity and boosting under-activity. They are regarded as harmonisers, and may be required for months – even years.

Tablets/capsules. Sarsaparilla, Ginseng, Prickly Ash, Kelp, Ginkgo, Wild Yam.

Powders. Formula. Ginseng 2; Kelp 1; Ginkgo 2. Dose: 500mg (two 00 capsules or one-third teaspoon) thrice daily.

Liquid Extracts. Formula as powders. Dose: one 5ml teaspoon thrice daily.

Tinctures. Double dose.

Teas. Alfalfa, Holy Thistle, Wormwood, Bogbean, Ginkgo. 

Health Source: Bartrams Encyclopedia of Herbal Medicine
Author: Health Encyclopedia
Underactivity of the pituitary gland, resulting in inadequate production of 1 or more pituitary hormones.

The effects depend on which hormones are affected.

Possible causes are a pituitary tumour, an abnormality affecting the hypothalamus, or injury to the pituitary gland.

Hypopituitarism may also follow surgery or radiotherapy of the pituitary gland.

Treatment involves replacing the deficient hormones.

Health Source: BMA Medical Dictionary
Author: The British Medical Association
Underactivity of the PITUITARY GLAND. It can cause dwar?sm, delayed puberty, impotence, infertility, AMENORRHOEA, hypothyroidism (see THYROID GLAND, DISEASES OF), and hypoadrenalism. Causes include tumours, irradiation of the gland, SARCOIDOSIS, and necrosis associated with post-partum haemorrhage (Sheehan’s syndrome).
Health Source: Medical Dictionary
Author: Health Dictionary
n. subnormal activity of the pituitary gland, causing *dwarfism in childhood and a syndrome of impaired sexual function, pallor, and premature ageing in adult life (see Simmonds disease).
Health Source: Oxford | Concise Colour Medical Dictionary
Author: Jonathan Law, Elizabeth Martin

Corticosteroids

The generic term for the group of hormones produced by the ADRENAL GLANDS, with a profound e?ect on mineral and glucose metabolism.

Many modi?cations have been devised of the basic steroid molecule in an attempt to keep useful therapeutic effects and minimise unwanted side-effects. The main corticosteroid hormones currently available are CORTISONE, HYDROCORTISONE, PREDNISONE, PREDNISOLONE, methyl prednisolone, triamcinolone, dexamethasone, betamethasone, paramethasone and de?azacort.

They are used clinically in three quite distinct circumstances. First they constitute replacement therapy where a patient is unable to produce their own steroids – for example, in adrenocortical insu?ciency or hypopituitarism. In this situation the dose is physiological – namely, the equivalent of the normal adrenal output under similar circumstances – and is not associated with any side-effects. Secondly, steroids are used to depress activity of the adrenal cortex in conditions where this is abnormally high or where the adrenal cortex is producing abnormal hormones, as occurs in some hirsute women.

The third application for corticosteroids is in suppressing the manifestations of disease in a wide variety of in?ammatory and allergic conditions, and in reducing antibody production in a number of AUTOIMMUNE DISORDERS. The in?ammatory reaction is normally part of the body’s defence mechanism and is to be encouraged rather than inhibited. However, in the case of those diseases in which the body’s reaction is disproportionate to the o?ending agent, such that it causes unpleasant symptoms or frank illness, the steroid hormones can inhibit this undesirable response. Although the underlying condition is not cured as a result, it may resolve spontaneously. When corticosteroids are used for their anti-in?ammatory properties, the dose is pharmacological; that is, higher – often much higher – than the normal physiological requirement. Indeed, the necessary dose may exceed the normal maximum output of the healthy adrenal gland, which is about 250–300 mg cortisol per day. When doses of this order are used there are inevitable risks and side-effects: a drug-induced CUSHING’S SYNDROME will result.

Corticosteroid treatment of short duration, as in angioneurotic OEDEMA of the larynx or other allergic crises, may at the same time be life-saving and without signi?cant risk (see URTICARIA). Prolonged therapy of such connective-tissue disorders, such as POLYARTERITIS NODOSA with its attendant hazards, is generally accepted because there are no other agents of therapeutic value. Similarly the absence of alternative medical treatment for such conditions as autoimmune haemolytic ANAEMIA establishes steroid therapy as the treatment of choice which few would dispute. The use of steroids in such chronic conditions as RHEUMATOID ARTHRITIS, ASTHMA and DERMATITIS needs careful assessment and monitoring.

Although there is a risk of ill-effects, these should be set against the misery and danger of unrelieved chronic asthma or the incapacity, frustration and psychological trauma of rheumatoid arthritis. Patients should carry cards giving details of their dosage and possible complications.

The incidence and severity of side-effects are related to the dose and duration of treatment. Prolonged daily treatment with 15 mg of prednisolone, or more, will cause hypercortisonism; less than 10 mg prednisolone a day may be tolerated by most patients inde?nitely. Inhaled steroids rarely produce any ill-e?ect apart from a propensity to oral thrush (CANDIDA infection) unless given in excessive doses.

General side-effects may include weight gain, fat distribution of the cushingoid type, ACNE and HIRSUTISM, AMENORRHOEA, striae and increased bruising tendency. The more serious complications which can occur during long-term treatment include HYPERTENSION, oedema, DIABETES MELLITUS, psychosis, infection, DYSPEPSIA and peptic ulceration, gastrointestinal haemorrhage, adrenal suppression, osteoporosis (see BONE, DISORDERS OF), myopathy (see MUSCLES, DISORDERS OF), sodium retention and potassium depletion.... corticosteroids

Gigantism

Excessive growth (especially in height), resulting from overproduction of growth hormone during childhood or adolescence by a tumour of the pituitary gland (see pituitary tumours). Untreated, the tumour may compress other hormone-producing cells in the pituitary gland, causing symptoms of hormone deficiency (see hypopituitarism). The condition may be treated with drugs such as bromocriptine that block the release of growth hormone, or by surgery or radiotherapy to remove or destroy the tumour. See also acromegaly.... gigantism

Corticotrophin-releasing Hormone

(CRH) a peptide hypothalamic hormone (of 41 amino acids) stimulating the release of *ACTH (adrenocorticotrophic hormone) from the anterior pituitary. Its own release is suppressed by a *negative feedback loop involving cortisol, and its action is increased by antidiuretic hormone (see vasopressin) and *angiotensin II. It can be administered intravenously as part of the CRH test, during which blood is analysed at 15-minute intervals for one hour for the ACTH response, which is excessive in cases of primary adrenal failure and suppressed in cases of anterior *hypopituitarism.... corticotrophin-releasing hormone

Human Menopausal Gonadotrophins

commercially available preparations of *follicle-stimulating hormone and *luteinizing hormone. They are used mainly to treat infertility in women with gonadotrophin deficiency due to hypopituitarism and to stimulate superovulation in women undergoing in vitro fertilization.... human menopausal gonadotrophins

Hypoadrenalism

n. subnormal activity of the *adrenal glands, which can be due to disease of the adrenal glands themselves (e.g. *Addison’s disease) or to a lack of stimulation from the pituitary hormone *ACTH as part of any condition causing *hypopituitarism.... hypoadrenalism

Hypophysitis

n. a rare condition of inflammation of the *pituitary gland (hypophysis). The main cause is an infiltration by lymphocytes, most commonly during or just after pregnancy. This usually presents as a mass lesion of the pituitary with visual-field loss and headache or with anterior *hypopituitarism, which may be total or just involve particular hormone systems. Around 50% of cases are associated with other autoimmune endocrine diseases, and antipituitary antibodies have been identified.... hypophysitis

Simmonds Disease

loss of sexual function, loss of weight, and other features of failure of the pituitary gland (*hypopituitarism) caused by trauma or tumours or occurring in women after childbirth complicated by bleeding (postpartum haemorrhage). [M. Simmonds (1885–1925), German physician]... simmonds disease

Obesity

A condition in which the energy stores of the body (mainly fat) are too large. It is a prevalent nutritional disorder in prosperous countries – increasingly so among children and young people. The Quetelet Index or BODY MASS INDEX, which relates weight in kilograms (W) to height2 in metres (H2), is a widely accepted way of classifying obesity in adults according to severity. For example:

Grade of obesity

BMI (W/H2) III >40 II 30–40 I 25–29·9 not obese <25

Causes Whatever the causes of obesity, the fact remains that energy intake (in the form of food and drink) must exceed energy output (in the form of activity and exercise) over a suf?ciently long period of time.

Obesity tends to aggregate in families. This has led to the suggestion that some people inherit a ‘thrifty’ gene which predisposes them to obesity in later life by lowering their energy output. Indeed, patients often attribute their obesity to such a metabolic defect. Total energy output is made up of the resting metabolic rate (RMR), which represents about 70 per cent of the total; the energy cost of physical activity; and thermogenesis, i.e. the increase in energy output in response to food intake, cold exposure, some drugs and psychological in?uences. In general, obese people are consistently found to have a higher RMR and total energy output, per person – and also when expressed against fat-free mass – than do their lean counterparts. Most obese people do not appear to have a reduced capacity for thermogenesis. Although a genetic component to obesity remains a possibility, it is unlikely to be great or to prevent weight loss from being possible in most patients by reducing energy intake. Environmental in?uences are believed to be more important in explaining the familial association in obesity.

An inactive lifestyle plays a minor role in the development of obesity, but it is unclear whether people are obese because they are inactive or are inactive because they are obese. For the majority of obese people, the explanation must lie in an excessive energy intake. Unfortunately, it is di?cult to demonstrate this directly since the methods used to assess how much people eat are unreliable. For most obese people it seems likely that the defect lies in their failure to regulate energy intake in response to a variety of cognitive factors (e.g. ease of ?tting of clothes) in the long term.

Unfortunately, it can be possible to identify by the time of their ?rst birthday, many of the children destined to be obese.

Rarely, obesity has an endocrine basis and is caused by hypothyroidism (see under THYROID GLAND, DISEASES OF), HYPOPITUITARISM, HYPOGONADISM or CUSHING’S SYNDROME.

Symptoms Obesity has adverse effects on MORBIDITY and mortality (see DEATH RATE) which are greatest in young adults and increase with the severity of obesity. It is associated with an increased mortality and/or morbidity from cardiovascular disease, non-insulin-dependent diabetes mellitus, diseases of the gall-bladder, osteoarthritis, hernia, gout and possibly certain cancers (i.e. colon, rectum and prostate in men, and breast, ovary, endometrium and cervix in women). Menstrual irregularities and ovulatory failure are often experienced by obese women. Obese people are also at greater risk when they undergo surgery. With the exception of gallstone formation, weight loss will reduce these health risks.

Treatment Creation of an energy de?cit is essential for weight loss to occur, so the initial line of treatment is a slimming diet. An average de?cit of 1,000 kcal/day (see CALORIE) will produce a loss of 1 kg of fat/week and should be aimed for. Theoretically, this can be achieved by increasing energy expenditure or reducing energy intake. In practice, a low-energy diet is the usual form of treatment since attempts to increase energy expenditure, either by physical exercise or a thermogenic drug, are relatively ine?ective.

Anorectic drugs, gastric stapling and jaw-wiring are sometimes used to treat severe obesity. They are said to aid compliance with a low-energy diet by either reducing hunger (anorectic drugs) or limiting the amount of food the patient can eat. Unfortunately, the long-term e?ectiveness of gastric stapling is not known, and it is debatable whether the modest reduction in weight achieved by use of anorectic drugs is worthwhile – although a new drug, ORLISTAT, is becoming available that reduces the amount of fat absorbed from food in the gastrointestinal tract. For some grossly obese patients, jaw-wiring can be helpful, but a regain of weight once the wires are removed must be prevented. These procedures carry a risk, so should be done only if an individual’s health is in danger.... obesity




Recent Searches